393548-53-3 Usage
Functional Groups
Imidazolidinedicarboxylic acid, carboxylic acid derivative, phenylmethyl ester, amino group, and butyl group
Molecular Structure
Complex structure with multiple functional groups and chiral centers
Stereochemistry
(4S)configuration at the chiral center
Application
Used in pharmaceutical research and development, particularly in the synthesis of drug candidates
Unique Properties
Potential for pharmacological activity due to its unique structural properties
Solubility
Soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO)
Stability
Stable under normal laboratory conditions, but sensitive to heat, light, and moisture
Purity
Typically synthesized with high purity for use in research and development
Safety
Handle with care, as it may have potential hazards depending on its pharmacological activity and concentration
Synthesis
Can be synthesized through various chemical reactions, often involving the formation of amide and ester bonds
Analytical Techniques
Characterized using techniques such as nuclear magnetic resonance (NMR), mass spectrometry (MS), and infrared (IR) spectroscopy
Biological Activity
May exhibit various biological activities depending on its specific structural features and the target it interacts with
Check Digit Verification of cas no
The CAS Registry Mumber 393548-53-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,3,5,4 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 393548-53:
(8*3)+(7*9)+(6*3)+(5*5)+(4*4)+(3*8)+(2*5)+(1*3)=183
183 % 10 = 3
So 393548-53-3 is a valid CAS Registry Number.
393548-53-3Relevant academic research and scientific papers
Arasappan, Ashok,Njoroge, F. George,Parekh, Tejal N.,Yang, Xiaozheng,Pichardo, John,Butkiewicz, Nancy,Prongay, Andrew,Yao, Nanhua,Girijavallabhan, Viyyoor
, p. 5751 - 5755 (2004)
Synthesis and HCV NS3 serine protease inhibitory activity of some novel 2-oxoimidazolidine-4-carboxylic acid derivatives are reported. X-ray structure of an inhibitor, 15c bound to the protease is presented. Synthesis and HCV NS3 serine protease inhibitor
